Tumour markers with unknown functions in gynaecological neoplasia
- PMID: 7416810
- DOI: 10.1007/BF02108583
Tumour markers with unknown functions in gynaecological neoplasia
Abstract
Pre- and post-operative ovarian cancer patients' sera were examined for the presence or circulating immune complexes using a variety of assay procedures. In contrast to findings with breast cancer patients' sera, sera from patients with other gynaecological tumours or with preclinical disease diagnosed by cytology, no evidence was obtained to indicate that circulating immune complexes were associated with ovarian cancer.
Similar articles
-
[Circulating T cells in patients with breast or genital cancers in the pre-therapeutic phase].Zentralbl Gynakol. 1989;111(12):816-23. Zentralbl Gynakol. 1989. PMID: 2788342 German.
-
Levels of circulating immune complexes in patients with ovarian cancer.Br J Obstet Gynaecol. 1982 Mar;89(3):231-7. doi: 10.1111/j.1471-0528.1982.tb03621.x. Br J Obstet Gynaecol. 1982. PMID: 7066260
-
[Carcinoembryonic antigen in gynecological oncology].Fortschr Med. 1978 Oct 5;96(37):1843-5. Fortschr Med. 1978. PMID: 700565 German.
-
Clinical use of gynaecologic tumour markers.Ann Chir Gynaecol. 1989;78(1):65-70. Ann Chir Gynaecol. 1989. PMID: 2547331 Review.
-
New trends in the surgery of gynaecological tumours.Acta Med Hung. 1994;50(3-4):195-203. Acta Med Hung. 1994. PMID: 8587833 Review.
Cited by
-
Circulating immune complexes in patients with benign and malignant colorectal tumours.Br J Surg. 1981 Jun;68(6):402-4. doi: 10.1002/bjs.1800680612. Br J Surg. 1981. PMID: 7237068 Free PMC article.